Abstract
Abstract
Background
We examined the cost-effectiveness of providing systematic smoking cessation interventions to oncology patients at point-of-care.
Methods
A decision analytic model was completed from the healthcare payer’s perspective and included all incident cancer cases involving patients who smoke in New Brunswick, Canada (n = 1040), cancer site stratifications, and risks of mortality, continued smoking, and cancer treatment failure over one year. Usual care (no cessation support) was compared to the standard Ottawa Model for Smoking Cessation (OMSC) intervention, and to OMSC plus unlimited cost-free stop smoking medication (OMSC + SSM), including nicotine replacement therapy, varenicline, or bupropion. Primary outcomes were incremental cost per quit (ICQ) and incremental cost per cancer treatment failure avoided (ICTFA).
Results
The ICQ was $C143 and ICTFA $C1193 for standard OMSC. The ICQ was $C503 and ICTFA was $C5952 for OMSC + SSM. The number needed to treat (NNT) to produce one quit was 9 for standard OMSC and 4 for OMSC + SSM, and the NNT to avoid one first-line treatment failure was 78 for OMSC and 45 for OMSC + SSM. Both were cost-effective in 100% of 1000 simulations.
Conclusions
Given the high clinical benefits and low incremental costs, systematic smoking cessation interventions should be a standard component of first-line cancer treatment.
Funder
Canadian Partnership Against Cancer Corporation www.partnershipagainstcancer.ca
Canadian Partnership Against Cancer Corporation https://www.partnershipagainstcancer.ca/
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Canadian Thoracic Society. The Human and Economic Burden of COPD: A Leading Cause of Hospital Admission in Canada. 2010. Available from: www.lung.ca/cts-sct/pdf/COPDReport_E.pdf.
2. Lightwood J, Collins, D, Lapsley H, Novotny TE. Estimating the costs of tobacco use. In: Jha P, Chaloupka, K, editor. Tobacco Control in Developing Countries. Cary, ND: Oxford University Press; 2000.
3. Public Health Agency of Canada. Tracking Heart Disease and Stroke in Canada 2009 October 28. 2013. Available from: www.phac-aspc.gc.ca/publicat/2009/cvd-avc/pdf/cvd-avs-2009-eng.pdf.
4. Mullen KA, Manuel DG, Hawken SJ, Pipe AL, Coyle D, Hobler LA, et al. Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes. Tob Control. 2017;26:293–9.
5. Department of Health and Human Services CfDCaP, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. 2014. Available from: https://www.hhs.gov/surgeongeneral/not-found/library/reports/50-years-of-progress/front-matter.pdf.